1. Home
  2. IOTR vs ANTX Comparison

IOTR vs ANTX Comparison

Compare IOTR & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IOTR
  • ANTX
  • Stock Information
  • Founded
  • IOTR 2019
  • ANTX 2017
  • Country
  • IOTR Singapore
  • ANTX United States
  • Employees
  • IOTR N/A
  • ANTX N/A
  • Industry
  • IOTR
  • ANTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • IOTR
  • ANTX Health Care
  • Exchange
  • IOTR NYSE
  • ANTX Nasdaq
  • Market Cap
  • IOTR 29.5M
  • ANTX 33.2M
  • IPO Year
  • IOTR 2025
  • ANTX 2022
  • Fundamental
  • Price
  • IOTR $0.52
  • ANTX $1.08
  • Analyst Decision
  • IOTR
  • ANTX Buy
  • Analyst Count
  • IOTR 0
  • ANTX 2
  • Target Price
  • IOTR N/A
  • ANTX $2.00
  • AVG Volume (30 Days)
  • IOTR 534.7K
  • ANTX 258.4K
  • Earning Date
  • IOTR 01-01-0001
  • ANTX 08-12-2025
  • Dividend Yield
  • IOTR N/A
  • ANTX N/A
  • EPS Growth
  • IOTR N/A
  • ANTX N/A
  • EPS
  • IOTR N/A
  • ANTX N/A
  • Revenue
  • IOTR $10,478,550.00
  • ANTX N/A
  • Revenue This Year
  • IOTR N/A
  • ANTX N/A
  • Revenue Next Year
  • IOTR N/A
  • ANTX N/A
  • P/E Ratio
  • IOTR N/A
  • ANTX N/A
  • Revenue Growth
  • IOTR 22.27
  • ANTX N/A
  • 52 Week Low
  • IOTR $0.31
  • ANTX $0.87
  • 52 Week High
  • IOTR $5.98
  • ANTX $3.07
  • Technical
  • Relative Strength Index (RSI)
  • IOTR N/A
  • ANTX 48.42
  • Support Level
  • IOTR N/A
  • ANTX $1.05
  • Resistance Level
  • IOTR N/A
  • ANTX $1.10
  • Average True Range (ATR)
  • IOTR 0.00
  • ANTX 0.04
  • MACD
  • IOTR 0.00
  • ANTX 0.00
  • Stochastic Oscillator
  • IOTR 0.00
  • ANTX 50.00

About ANTX AN2 Therapeutics Inc.

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.

Share on Social Networks: